Synopsis
Synopsis
0
VMF
0
Weekly News Recap #Phispers
1. Bromide, Glycopyrronium
2. Glycopyrronium
3. Glycopyrronium Bromide
4. Nva 237
5. Nva-237
6. Nva237
7. Pyrrolidinium, 3-((cyclopentylhydroxyphenylacetyl)oxy)-1,1-dimethyl-, Bromide
1. 596-51-0
2. Glycopyrrolate Bromide
3. Robinul
4. Glycopyrronium Bromide
5. Gastrodyn
6. Nodapton
7. Tarodyl
8. Tarodyn
9. Asecryl
10. Cuvposa
11. Glycopyrronii Bromidum
12. Robanul
13. Ahr-504
14. Bromuro De Glicopirronio
15. Bromure De Glycopyrronium
16. Nva-237
17. Robinal
18. Seebri Neohaler
19. 3-hydroxy-1,1-dimethylpyrrolidinium Bromide Alpha-cyclopentylmandelate
20. Seebri
21. 1,1-dimethyl-3-hydroxypyrrolidinium Bromide Alpha-cyclopentylmandelate
22. 1-methyl-3-pyrrolidyl Alpha-phenylcyclopentaneglycolate Methobromide
23. 3-(2-cyclopentyl-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium Bromide
24. Pyrrolidinium, 3-[(cyclopentylhydroxyphenylacetyl)oxy]-1,1-dimethyl-,bromide
25. Ad-237
26. Pt-001
27. Nsc-250836
28. Nsc-251251
29. Nsc-251252
30. Copyrrolate
31. Dsstox_cid_3109
32. 3-(2-cyclopentyl-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidinium Bromide
33. (1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenylacetate Bromide
34. Dsstox_rid_76878
35. Dsstox_gsid_23109
36. Glycopyrronium (bromide);glycopyrrolate (bromide)
37. Nva237
38. Robinul Forte
39. Pyrrolidinium,1-dimethyl-, Bromide
40. Seebri Breezhaler
41. 53808-86-9
42. (1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenylacetate;bromide
43. Smr000469282
44. Glycopyrrolate, Erythro-
45. Nsc 250836
46. Nsc 251251
47. Nsc 251252
48. Org-nc-45
49. Nsc250836
50. Nsc251251
51. Nsc251252
52. (2s,3's)-glycopyrrolate
53. Ahr 504
54. Glycopyrronium (as Bromide)
55. Nva 237
56. Glycopyrronii Bromidum [inn-latin]
57. Ncgc00179456-02
58. Wln: T5ktj A1 A1 Covxqr&- Al5tj &q &e
59. Einecs 209-887-0
60. Mfcd00072137
61. Bromure De Glycopyrronium [inn-french]
62. Bromuro De Glicopirronio [inn-spanish]
63. Chf5259
64. Glycopyrrolate [usan:usp]
65. Pt001
66. Chf-5259
67. Lonhala Magnair
68. Pyrrolidinium,1-dimethyl-, Bromide, .alpha.-cyclopentylmandelate
69. 1,1-dimethyl-3-hydroxypyrrolidinium Bromide .alpha.-cyclopentylmandelate
70. 1-methyl-3-pyrrolidinyl .alpha.-phenylcyclopentaneglycolate Methobromide
71. 3-hydroxy-1,1-dimethylpyrrolidinium Bromide-.alpha.-cyclopentylmandelate
72. Mandelic Acid, Ester With 3-hydroxy-1,1-dimethylpyrrolidinium Bromide
73. Cuvposa (tn)
74. Robinul (tn)
75. Glycopyrrolate (usp)
76. .beta.-1-methyl-3-pyrrolidyl-.alpha.-cyclopentylmandelate Methobromide
77. Seebri Breezhaler (tn)
78. Cas-596-51-0
79. Glycopyrrone Bromide
80. Schembl41436
81. Glycopyrronium Bromide ,(s)
82. Mls001424112
83. Mls002222301
84. 3-hydroxy-1,1-dimethylpyrrolidinium Bromide .alpha.-cyclopentylmandelate
85. Chembl1201027
86. Dtxsid6023109
87. Chebi:90972
88. Glycopyrrolate, >=98% (hplc)
89. Glycopyrronium Bromide (jan/inn)
90. Hms1570e14
91. Hms2051p12
92. Hms2094a05
93. Hms2097e14
94. Hms2235f12
95. Hms3259p04
96. Hms3369f10
97. Hms3393p12
98. Hms3714e14
99. Hms3885p14
100. Pharmakon1600-01505753
101. Amy22352
102. Bcp07110
103. Bcp33298
104. Chf-5992
105. Ex-a4155
106. Tox21_113144
107. Tox21_113145
108. Nsc759238
109. S4660
110. Akos015962136
111. Pyrrolidinium, 1,1-dimethyl-3-hydroxy-, Bromide, Alpha-cyclopentylmandelate
112. Pyrrolidinium, 3-hydroxy-1,1-dimethyl-, Bromide, Alpha-cyclopentylmandelate
113. Tox21_113144_1
114. Ccg-101030
115. Ccg-213543
116. Cs-1763
117. Nc00280
118. Nc00694
119. Nsc-759238
120. Ncgc00179456-04
121. Ac-23382
122. Hy-17465
123. Glycopyrrolate Erythro Isomer (ss-isomer)
124. Ft-0626787
125. G0392
126. D00540
127. A832400
128. Sr-01000763650
129. Sr-01000763650-3
130. Q27162963
131. Glycopyrrolate Erythro Isomer (mixture Of Rr-isomer And Ss-isomer)
132. Glycopyrrolate, United States Pharmacopeia (usp) Reference Standard
133. Glycopyrronium Bromide, European Pharmacopoeia (ep) Reference Standard
134. Glycopyrronium Impurity N, European Pharmacopoeia (ep) Reference Standard
135. 3-(2-cyclopentyl-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-iumbromide
136. 3-{[cyclopentyl(hydroxy)phenylacetyl]oxy}-1,1-dimethylpyrrolidin-1-ium Bromide
137. Glycopyrronium For Peak Identification, European Pharmacopoeia (ep) Reference Standard
Molecular Weight | 398.3 g/mol |
---|---|
Molecular Formula | C19H28BrNO3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 5 |
Exact Mass | 397.12526 g/mol |
Monoisotopic Mass | 397.12526 g/mol |
Topological Polar Surface Area | 46.5 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 424 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 8 | |
---|---|
Drug Name | Cuvposa |
PubMed Health | Glycopyrrolate |
Drug Classes | Cholinergic Antagonist, Gastrointestinal Agent |
Drug Label | CUVPOSA is an anticholinergic drug available as an oral solution containing 1 mg glycopyrrolate per 5 mL. The chemical name for glycopyrrolate is pyrrolidinium, 3-[(cyclopentylhydroxyphenylacetyl) oxy]-1,1-dimethyl-,bromide. The chemical structure is... |
Active Ingredient | Glycopyrrolate |
Dosage Form | Solution |
Route | Oral |
Strength | 1mg/5ml |
Market Status | Prescription |
Company | Merz Pharms |
2 of 8 | |
---|---|
Drug Name | Glycopyrrolate |
PubMed Health | Glycopyrrolate |
Drug Classes | Cholinergic Antagonist, Gastrointestinal Agent |
Drug Label | Glycopyrrolate tablets contain the synthetic anticholinergic glycopyrrolate. Glycopyrrolate is a quaternary ammonium compound with the following chemical name:3-[(cyclopentylhydroxyphenylacetyl)oxy]-1,1-dimethylpyrrolidinium bromide. Its empirical fo... |
Active Ingredient | Glycopyrrolate |
Dosage Form | Tablet; Injectable |
Route | Injection; Oral |
Strength | 1mg; 0.2mg/ml; 1.5mg; 2mg |
Market Status | Prescription |
Company | Stason Pharms; Vintage Pharms; Ranbaxy; Aurolife Pharma; Excellium; Hikma Farmaceutica; Par Pharm; Vintage; Luitpold; Dr Reddys Labs; Nexgen Pharma |
3 of 8 | |
---|---|
Drug Name | Robinul |
PubMed Health | Glycopyrrolate |
Drug Classes | Cholinergic Antagonist, Gastrointestinal Agent |
Drug Label | ROBINUL (glycopyrrolate) Injection is a synthetic anticholinergic agent. Each 1 mL contains:Glycopyrrolate, USP 0.2 mgWater for Injection, USP q.s.Benzyl Alcohol, NF 0.9% (preservative)pH adjusted, when necessary, with hydrochloric acid and/or sodium... |
Active Ingredient | Glycopyrrolate |
Dosage Form | Tablet; Injectable |
Route | Injection; Oral |
Strength | 1mg; 0.2mg/ml |
Market Status | Prescription |
Company | Shionogi; Hikma Maple |
4 of 8 | |
---|---|
Drug Name | Robinul forte |
PubMed Health | Glycopyrrolate (By mouth) |
Drug Classes | Cholinergic Antagonist, Gastrointestinal Agent |
Drug Label | Robinul and Robinul Forte tablets contain the synthetic anticholinergic, glycopyrrolate. Glycopyrrolate is a quaternary ammonium compound with the following chemical name: 3-[(cyclopentylhydroxyphenylacetyl)oxy]-1, 1-dimethylpyrrolidinium bromide... |
Active Ingredient | Glycopyrrolate |
Dosage Form | Tablet |
Route | Oral |
Strength | 2mg |
Market Status | Prescription |
Company | Shionogi |
5 of 8 | |
---|---|
Drug Name | Cuvposa |
PubMed Health | Glycopyrrolate |
Drug Classes | Cholinergic Antagonist, Gastrointestinal Agent |
Drug Label | CUVPOSA is an anticholinergic drug available as an oral solution containing 1 mg glycopyrrolate per 5 mL. The chemical name for glycopyrrolate is pyrrolidinium, 3-[(cyclopentylhydroxyphenylacetyl) oxy]-1,1-dimethyl-,bromide. The chemical structure is... |
Active Ingredient | Glycopyrrolate |
Dosage Form | Solution |
Route | Oral |
Strength | 1mg/5ml |
Market Status | Prescription |
Company | Merz Pharms |
6 of 8 | |
---|---|
Drug Name | Glycopyrrolate |
PubMed Health | Glycopyrrolate |
Drug Classes | Cholinergic Antagonist, Gastrointestinal Agent |
Drug Label | Glycopyrrolate tablets contain the synthetic anticholinergic glycopyrrolate. Glycopyrrolate is a quaternary ammonium compound with the following chemical name:3-[(cyclopentylhydroxyphenylacetyl)oxy]-1,1-dimethylpyrrolidinium bromide. Its empirical fo... |
Active Ingredient | Glycopyrrolate |
Dosage Form | Tablet; Injectable |
Route | Injection; Oral |
Strength | 1mg; 0.2mg/ml; 1.5mg; 2mg |
Market Status | Prescription |
Company | Stason Pharms; Vintage Pharms; Ranbaxy; Aurolife Pharma; Excellium; Hikma Farmaceutica; Par Pharm; Vintage; Luitpold; Dr Reddys Labs; Nexgen Pharma |
7 of 8 | |
---|---|
Drug Name | Robinul |
PubMed Health | Glycopyrrolate |
Drug Classes | Cholinergic Antagonist, Gastrointestinal Agent |
Drug Label | ROBINUL (glycopyrrolate) Injection is a synthetic anticholinergic agent. Each 1 mL contains:Glycopyrrolate, USP 0.2 mgWater for Injection, USP q.s.Benzyl Alcohol, NF 0.9% (preservative)pH adjusted, when necessary, with hydrochloric acid and/or sodium... |
Active Ingredient | Glycopyrrolate |
Dosage Form | Tablet; Injectable |
Route | Injection; Oral |
Strength | 1mg; 0.2mg/ml |
Market Status | Prescription |
Company | Shionogi; Hikma Maple |
8 of 8 | |
---|---|
Drug Name | Robinul forte |
PubMed Health | Glycopyrrolate (By mouth) |
Drug Classes | Cholinergic Antagonist, Gastrointestinal Agent |
Drug Label | Robinul and Robinul Forte tablets contain the synthetic anticholinergic, glycopyrrolate. Glycopyrrolate is a quaternary ammonium compound with the following chemical name: 3-[(cyclopentylhydroxyphenylacetyl)oxy]-1, 1-dimethylpyrrolidinium bromide... |
Active Ingredient | Glycopyrrolate |
Dosage Form | Tablet |
Route | Oral |
Strength | 2mg |
Market Status | Prescription |
Company | Shionogi |
Tovanor Breezhaler is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Seebri Breezhaler is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Enurev Breezhaler is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Symptomatic treatment of severe sialorrhoea (chronic pathological drooling) in children and adolescents aged 3 years and older with chronic neurological disorders.
Treatment of sialorrhoea
Chronic obstructive pulmonary disease
Treatment of sialorrhoea
Treatment of hyperhidrosis
Muscarinic Antagonists
Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)
Adjuvants, Anesthesia
Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage. (See all compounds classified as Adjuvants, Anesthesia.)
R03BB06
R03BB06
R03BB06
A03AB02
A03AB02
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
A - Alimentary tract and metabolism
A03 - Drugs for functional gastrointestinal disorders
A03A - Drugs for functional gastrointestinal disorders
A03AB - Synthetic anticholinergics, quaternary ammonium compounds
A03AB02 - Glycopyrronium bromide
R - Respiratory system
R03 - Drugs for obstructive airway diseases
R03B - Other drugs for obstructive airway diseases, inhalants
R03BB - Anticholinergics
R03BB06 - Glycopyrronium bromide
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-02-16
Pay. Date : 2017-07-06
DMF Number : 31836
Submission : 2017-07-22
Status : Active
Type : II
Certificate Number : R1-CEP 2017-182 - Rev 00
Issue Date : 2023-08-17
Type : Chemical
Substance Number : 1783
Status : Valid
NDC Package Code : 64567-0018
Start Marketing Date : 2017-07-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Samoh Pharmaceutical Co., Ltd.
Registration Date : 2020-11-03
Registration Number : 20201103-211-J-782
Manufacturer Name : INKE SA
Manufacturer Address : C/Argent 1, Area Industrial del Llobregat 08755 Castellbisbal Barcelona, Spain
Available Reg Filing : CN |
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-10-05
Pay. Date : 2013-09-30
DMF Number : 18106
Submission : 2005-02-22
Status : Active
Type : II
Certificate Number : R1-CEP 2012-129 - Rev 01
Issue Date : 2020-07-30
Type : Chemical
Substance Number : 1783
Status : Valid
Registration Number : 230MF10066
Registrant's Address : 21,chemin de la Sauvegarde 21 Ecully Parc - CS 33167 69134 Ecully Cedex France
Initial Date of Registration : 2018-05-21
Latest Date of Registration : --
NDC Package Code : 51014-7146
Start Marketing Date : 2009-08-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF, CA, CN |
Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26470
Submission : 2012-09-17
Status : Active
Type : II
Certificate Number : R0-CEP 2020-077 - Rev 00
Issue Date : 2021-09-14
Type : Chemical
Substance Number : 1783
Status : Valid
Date of Issue : 2019-01-21
Valid Till : 2022-01-20
Written Confirmation Number : WC-286
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39337
Submission : 2024-05-29
Status : Active
Type : II
NDC Package Code : 82245-0121
Start Marketing Date : 2024-03-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19026
Submission : 2005-12-10
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-06-20
Pay. Date : 2019-05-03
DMF Number : 33806
Submission : 2019-05-08
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39692
Submission : 2024-03-19
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-02-16
Pay. Date : 2017-07-06
DMF Number : 31836
Submission : 2017-07-22
Status : Active
Type : II
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
GDUFA
DMF Review : Complete
Rev. Date : 2013-10-05
Pay. Date : 2013-09-30
DMF Number : 18106
Submission : 2005-02-22
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19026
Submission : 2005-12-10
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2015-03-13
Pay. Date : 2015-03-06
DMF Number : 16972
Submission : 2003-11-13
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6044
Submission : 1985-10-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16967
Submission : 2003-11-17
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20578
Submission : 2007-05-31
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2012-11-23
Pay. Date : 2012-12-06
DMF Number : 19710
Submission : 2006-08-28
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18727
Submission : 2005-08-31
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 430
Submission : 1961-04-18
Status : Inactive
Type : II
Glycopyrronium bromide, Micronised, non-micronised
Certificate Number : R1-CEP 2017-182 - Rev 00
Status : Valid
Issue Date : 2023-08-17
Type : Chemical
Substance Number : 1783
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
Certificate Number : R1-CEP 2012-129 - Rev 01
Status : Valid
Issue Date : 2020-07-30
Type : Chemical
Substance Number : 1783
Certificate Number : R1-CEP 2014-194 - Rev 01
Status : Valid
Issue Date : 2021-02-18
Type : Chemical
Substance Number : 1783
Certificate Number : R0-CEP 2021-154 - Rev 00
Status : Valid
Issue Date : 2022-11-16
Type : Chemical
Substance Number : 1783
Certificate Number : R1-CEP 2012-017 - Rev 01
Status : Valid
Issue Date : 2020-12-01
Type : Chemical
Substance Number : 1783
Glycopyrronium bromide, Micronised, non-micronised
Certificate Number : R0-CEP 2021-222 - Rev 01
Status : Valid
Issue Date : 2023-01-16
Type : Chemical
Substance Number : 1783
Certificate Number : R1-CEP 2013-110 - Rev 04
Status : Valid
Issue Date : 2023-08-23
Type : Chemical
Substance Number : 1783
Certificate Number : R0-CEP 2020-077 - Rev 00
Status : Valid
Issue Date : 2021-09-14
Type : Chemical
Substance Number : 1783
Certificate Number : R0-CEP 2021-268 - Rev 00
Status : Valid
Issue Date : 2023-01-11
Type : Chemical
Substance Number : 1783
Date of Issue : 2019-10-31
Valid Till : 2022-07-02
Written Confirmation Number : WC-0124
Address of the Firm : Plot No.28 A, IDA, Nacharam, Hyderabad, AP
Glycopyrrolate USP/ Glycopyrronium Bromide EP
Date of Issue : 2022-06-08
Valid Till : 2025-07-21
Written Confirmation Number : WC-0045nA2
Address of the Firm : Plot No. E-7, 8, 9 MIDC, Industrial Area, Chikalthana, Aurangabad-431006
Date of Issue : 2013-08-08
Valid Till : 2016-07-02
Written Confirmation Number : WC-0223
Address of the Firm : Plot B-1 Wagle Industrial Eastate Thane W 400604 Maharashtra State
Date of Issue : 2019-01-21
Valid Till : 2022-01-20
Written Confirmation Number : WC-286
Address of the Firm : No. 8C & 9A, KIADB Industrial Area, Doddaballapur, Bangalore Dist-561023
Date of Issue : 2019-07-15
Valid Till : 2022-07-14
Written Confirmation Number : WC-0042
Address of the Firm : Plot No.262, 263, IDA, Pashamylaram, Medak District, A.P
Glycopyrrolate USP/Glycopyrronium Bromide EP/BP
Date of Issue : 2022-02-25
Valid Till : 2022-07-07
Written Confirmation Number : WC-0165A3
Address of the Firm : Plot No. A-1/2102, 2103, Phase-III GIDC, Vapi-396 195, Valsad, Gujarat, India
About the Company : Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse the...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
About the Company : Since its inception in 2003, Seqens has grown to become a global leader in pharmaceutical solutions and specialty ingredients. Seqens supports its customers in developing, scaling ...
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.
About the Company : Vamsi Labs, established in 1991, is a leading Indian API manufacturer. Specializing in anti-asthmatic, anti-migraine & anti-psychotic APIs, it caters to domestic & international ma...
About the Company : Public health is always an imperative that implies immense responsibility, not a mere re-adjustable option. As a company operating under world’s second largest industry of Pharma...
About the Company : We produce Active Pharmaceutical Ingredients (APIs) providing integrated full-service capabilities. Olon’s ability to develop and manufacture Active Pharmaceutical Ingredients (...
About the Company : Headquartered in Southern California, Stason entered the commercial generic market in 1994 and today continues to manufacture and market these products through our global network o...
About the Company : Since 2005, Tai Heng has been servicing global generic companies through vertically integrated drug development program. From API to commercial product, we offer customers a comple...
About the Company : Tooba Pharmaceuticals Private Limited (TPPL) is a GMP Certified manufacturer of API Bulk Drugs and Intermediates, with state-of-the-art manufacturing facility. TPPL retains its ...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?